Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A new mouse model for vitiligo helps study immune responses and potential treatments.

COVID-19 can trigger a relapsing form of hair loss, requiring long-term treatment strategies.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Hair transplant can cause hard-to-treat keloids in some patients.

Combination therapies might work better for some vitiligo patients, but results vary.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.